What are you looking for today?

Holley, Mia, Wilkes, Scott, Moss, Ellen Dorothea, Maxwell, Ian, Dew, Rosie and Razvi, Salman (2025) Impact of Higher versus Lower dose Levothyroxine treatment on Vascular and Bone Health in Older People with Hypothyroidism: protocol for an Emulation of a Target Trial. [Pre-registration]

Document

Abstract

Abstract

Background: Levothyroxine (LT4) is the standard treatment for hypothyroidism, but the optimal dosing for older adults remains unclear. Both higher and lower doses of LT4 may have differential effects on cardiovascular and bone health, with potential risks in ageing populations. We plan an emulated target trial aimed at assessing the impact of lower versus higher LT4 doses on cardiovascular events and bone health outcomes in older individuals with hypothyroidism.
Methods: We will utilise real-world data from a large, observational cohort of older adults with hypothyroidism residing in the United Kingdom from the Primary care-based THIN (The Health Improvement Network) electronic health records database. We will emulate a randomised trial comparing lower (≤1.0 µg/kg/day) versus higher (>1.0 µg/kg/day) LT4 doses. The primary outcomes will be vascular events (including myocardial infarction, stroke, and heart failure) and bone health outcomes (fragility fractures or a diagnosis of osteoporosis). Secondary outcomes include all-cause mortality and healthcare utilisation rates. We will employ inverse probability of treatment weighting (IPTW) to adjust for relevant confounders and emulate randomisation. Cox proportional hazard models (weighted by IPTWs) will be used to estimate treatment effects on outcomes. The study period will be from 2006 to 2021, with follow-up durations ranging up to 10 years. Sensitivity analyses will be performed to confirm the robustness of the findings.
Dissemination and ethics: No ethical approval is needed to use this retrospective anonymised database. The results will be disseminated during conferences and through publication in a peer-reviewed scientific journal.
Conclusions: This emulated target trial of observational data from Primary Care will evaluate if higher doses of LT4 are associated with increased risks of cardiovascular events and bone health events, as well as higher mortality, compared to lower doses. The findings of this research will provide valuable information on whether lower LT4 doses may be safe and efficacious in this population, balancing effective thyroid hormone replacement with minimized cardiovascular and bone health risks. Based on the results of this research, further randomised trials will be planned to confirm these results and guide clinical practice.

Item Type: Pre-registration
Depositing User: Mia Holley
URI: https://sure.sunderland.ac.uk/id/eprint/19274

Further Details

More Information

Depositing User

Identifiers

Item ID
19274

Users with ORCIDS

ORCID for Mia Holley
ORCID for Scott Wilkes

Catalogue record

Date Deposited
01 Aug 2025 11:28
Last Modified
01 Aug 2025 11:28

Contributors

Author
Author
Ellen Dorothea Moss
Author
Ian Maxwell
Author
Rosie Dew
Author
Salman Razvi

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year